Notice of Effectiveness

ACADIA PHARMACEUTICALS INC Filed 2025-05-23 Acc 9999999995-25-001730

Documents 1

2025-05-29 8-K Shareholder vote results
2025-05-23 EFFECT Notice of Effectiveness
2025-05-21 CORRESP Correspondence Between Filers and SEC Staff
2025-05-20 8-K Material agreement · Other events
2025-05-19 4 PRINCIPAL ACCOUNTING OFFICER sold 4,000 shares at an average $22.50 ($90,000)
2025-05-19 4 EVP, CHIEF FINANCIAL OFFICER sold 2,000 shares at $25.00 ($50,000)
2012-12-28 EFFECT Notice of Effectiveness

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading xslEFFECTX01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…